Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Ulrike Lorch, MD
Man Max 99 years
Ulrike Lorch, MD
Update Il y a 4 ans
Safety, Tolerability & PK of AZD0328 in Caucasian & Japanese
This study will be performed to evaluate the safety, tolerability and pharmacokinetics of single and multiple doses of AZD0328 when administered to Japanese and Caucasian healthy male volu...
Country
United Kingdom
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Ulrike Lorch, MD FRCA FFPM
Update Il y a 4 ans
Open Label Pharmacokinetic Study of OZ439 and Piperaquine on Administration of OZ439+TPGS Granules for Oral Suspension Alone or With Either Piperaquine Phosphate Tablets or Granules for Oral Solution in Healthy Volunteers
A healthy volunteer study to characterise the exposure of the two study medications, following administration of OZ439 + TPGS granules with piperaquine phosphate granules (intended for chi...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Ulrike Lorch, MD MFPM FRCA
Update Il y a 4 ans
A Single and Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Japanese Subjects
This is a single centre, Double blinded, Randomised, Placebo-controlled, Parallel group study to access the safety, tolerability, and pharmacokinetics of Inhaled AZD9164 after administrati...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Ulrike Lorch, MD
Update Il y a 4 ans
Dose-escalation Study to Assess Selumetinib Safety, Tolerability and PK
The purpose of the study is to assess the safety, tolerability and PK of selumetinib (AZD6244; ARRY-142886) (Hyd-Sulfate) in healthy male Japanese and non-Japanese Asian volunteers followi...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Ulrike Lorch, MD FRCA FFPM
Update Il y a 4 ans
Food and Insulin Effect on QT/QTC Interval of ECG
Moxifloxacin is routinely used as a probe to confirm assay sensitivity in thorough electrocardiogram (ECG) studies. It has been shown that a meal shortens the QT interval, which may affect...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Ulrike Lorch, MD MFPM FRCA
Update Il y a 4 ans
Japanese Single and Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic (PK) & Pharmacodynamic (PD) Study of AZD7687
This is a study in Japanese healthy volunteers to determine the safety and tolerability of the compound AZD7687. It will also assess how the body handles the drug and how it responds to th...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Ulrike Lorch, MD
Update Il y a 4 ans
A Comparative Bioavailability Study of Lomitapide 20 mg Intact vs Sprinkled
To compare the relative bioavailability of lomitapide when administered by sprinkling the contents of a 20 mg capsule of lomitapide in applesauce or in mashed banana to a single oral intac...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Ulrike Lorch, MD FRCA FFPM
Update Il y a 4 ans
Effect of Glucose on QTc Interval in Type 1 Diabetes
High blood glucose levels (hyperglycaemia) and Moxifloxacin (a commonly used antibiotic) have both been shown independently to affect heart activity in healthy volunteers as recorded by EC...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Ulrike Lorch, MD MFPM FRCA
Update Il y a 4 ans
AZD2423 Single Ascending Dose Study in Healthy Japanese Subjects
This is a Phase I, single centre, randomised, double-blind, placebo-controlled, parallel group study to assess the safety, tolerability and pharmacokinetics of AZD2423 following single asc...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Ulrike Lorch, MD FRCA FFPM
Update Il y a 4 ans
Healthy Volunteer Study of the Pharmacokinetics of Oral Piperaquine With OZ439 + TPGS Formulation in the Fasted State
Piperaquine tablets (coated) + OZ439 granules + TPGS granules will be co-administered in Phase IIb (adults). However, safety and PK data (for OZ439 plus piperaquine) were obtained using pi...
Country
None
organs
None
Specialty
None
Closed trial
More information
1
2
Next